Navigation Links
StockCall Scrutinizes Pfizer, Merck & Co., Johnson & Johnson, and AbbVie
Date:4/10/2013

LONDON, April 10, 2013 /PRNewswire/ --

The Dow Jones Index closed at an all time high at 14,673.46, up 0.41 percent while NASDAQ was up 0.48 percent to end yesterday's session at 3,237.86. Similarly, S&P also finished Tuesday's trading session on a positive note at 1,568.61, up 0.35 percent. The markets showed across the board improvement and a bullish trend. Our research team took a look at the Healthcare sector, focusing on the major drug makers industry which include including companies like Pfizer Inc. (NYSE: PFE), Merck & Co. Inc. (NYSE: MRK), Johnson & Johnson (NYSE: JNJ) and AbbVie Inc. (NYSE: ABBV). StockCall reviewed the Drug Manufacturers - Major industry and chose PFE, MRK, JNJ, and ABBV for its technical coverage. These free reports can be seen for free at

http://www.stockcall.com/signup

Pfizer Inc. is trading below its long-term moving average price, indicating a neutral trend. It also closed its latest trading session at $29.11, down 0.17 percent. The stock made its downward movement with below average volume of 27.53 million shares. Pfizer Inc. trades at Price/Earnings ratio of 23.10, in-line with industry average, making the stock a fairly priced proposition. However, the stock provided good return to its holders as it appreciated 16.95 percent this year. Pfizer's stock also gained 30.3 percent in the past 52 weeks, and it oscillated between $21.40 and $29.44 during this time period. Download the free research on PFE by signing up now at

http://www.StockCall.com/PFE041013.pdf

Merck & Co. Inc. is currently trading in overbought territory
'/>"/>

SOURCE StockCall.com
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Leaders from Pfizer, Novartis and J&J Challenge Industry to Disrupt R&D
2. Acumen Pharmaceuticals Regains Worldwide Rights to Anti-ADDL Antibody Therapeutics and Diagnostics for Alzheimers Disease From Merck
3. Ambrx Collaborates with Merck to Design and Develop Biologic Drug Conjugates
4. Merck Company Foundation Announces HIV Care Collaborative with Atlanta, Houston and Philadelphia Health Departments
5. Symphogen Grants Exclusive Worldwide License of Phase II Oncology Drug Candidate Sym004 to Merck KGaA
6. Merck Serono et lInstitut Feinstein vont sassocier pour développer un programme pré-clinique portant sur les maladies inflammatoires
7. Generex Provides Update on Generex Oral-lyn™ Clinical & Regulatory Program
8. The Law Firm of Levi & Korsinsky, LLP Launches an Investigation Into Possible Securities Laws Violations by Pacific Biosciences of California, Inc.
9. Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie
10. Chandler Chicco Companies Acquires Haas & Health Partner Public Relations and SanCom Creative Communication Solutions, Creating Unrivalled Healthcare Communication Capability in Germany
11. Generex Subsidiary Antigen Express Provides Update on AE37 Cancer Vaccines Clinical & Regulatory Strategy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... Research and Markets has ... Diagnostics Market (Product types, Application, Technology, End User ... Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation ... their offering. This new report ... users and Geography) Global Size, Industry Analysis, Trends, ...
(Date:10/22/2014)... October 21, 2014 Shimadzu Scientific Instruments ... data tool for the pain management and clinical markets. ... processing and review by allowing users to highlight and ... , QuantAnalytics allows analysts to filter results by ... data processing by eliminating the need to sift through ...
(Date:10/22/2014)... Khaimah, UAE (PRWEB) October 22, 2014 ... life science and healthcare projects, announces the addition of ... DRCOG DCH to its advisory team. Dr. Siddiqui will ... team. , A graduate of University College ... was subsequently degreed in medicine in 2001. With further ...
(Date:10/22/2014)... /PRNewswire/ - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ... its Oral Amphotericin B program.  The company recently ... work involving samples from HIV/AIDS patients exposed ... pre clinical studies and regulatory filings to move ... utilizing approximately $700,000 of funding and technological advice ...
Breaking Biology Technology:Global DNA Diagnostics Market (Product types, Application, Technology, End User and Geography) - Forecast to 2020 2Global DNA Diagnostics Market (Product types, Application, Technology, End User and Geography) - Forecast to 2020 3Shimadzu Releases QuantAnalytics Open Access LCMS Software Package for Clinical Applications 2Dr. Yousef Siddiqui joins the Grace Century Advisory Team 2iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 2iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 3
... Research and,Engineering (IMRE), led by Professor Christian Joachim 1 ... first in the world to invent a,molecular gear of ... This achievement marks a radical shift in the scientific ... 2009 2 in Nature Materials 3 ...
... ... and control devices and level gauges, today announced that it has acquired certain assets ... liquid delivery solutions for the global semiconductor, solar, and electronics industries. Financial terms of ... ...
... Role of Chairman of the Board - , , ... INSM ), a biopharmaceutical company, today announced that Geoffrey Allan, ... Chairman of the Board of Directors, effective immediately, due to ... President, Chief Executive Officer and Chairman of the Board since ...
Cached Biology Technology:A*STAR scientists invent the world's only controllable molecule gear of minuscule size of 1.2nm 2Brooks Instrument Completes Acquisition of Celerity's Instrumentation Division 2Brooks Instrument Completes Acquisition of Celerity's Instrumentation Division 3Insmed CEO Resigns Due to Health Concerns 2Insmed CEO Resigns Due to Health Concerns 3
(Date:10/22/2014)... 21, 2014 Aware, Inc. (NASDAQ: AWRE ... reported financial results for its third quarter ended September 30, ... was $6.0 million, an increase of 40% compared to $4.3 ... the third quarter of 2014 was $4.1 million compared to ... income in the current three month period was primarily due ...
(Date:10/18/2014)... a group of 2,000 patients referred for evaluation ... potential molecular diagnosis for 25 percent, including detection ... new mutations contributing to disease, according to a ... is being released to coincide with the American ... sequencing analyzes the exons or coding regions of ...
(Date:10/17/2014)... German . ... in order to reproduce? And why are there two sexes ... latest issue of the research journal Molecular Human Reproduction ... Ramm from Bielefeld University Bielefeld has compiled this special issue ... a female to copulate with several males in quick succession ...
Breaking Biology News(10 mins):Aware, Inc. Reports Third Quarter 2014 Financial Results 2Aware, Inc. Reports Third Quarter 2014 Financial Results 3Aware, Inc. Reports Third Quarter 2014 Financial Results 4Aware, Inc. Reports Third Quarter 2014 Financial Results 5Aware, Inc. Reports Third Quarter 2014 Financial Results 6Aware, Inc. Reports Third Quarter 2014 Financial Results 7Whole-exome sequencing shows potential as diagnostic tool 2Sperm wars 2
... sour apple and you destroy them plant cell vacuoles. ... plant cells, only little was known about how these cellular ... their way there. Scientists at the Technische Universitaet Muenchen (TUM) ... of vacuoles. In the process they uncovered new clues that ...
... release is available in Spanish . ... tool for improving the expression of desirable genes in rice ... the most good. Roger Thilmony, a geneticist with USDA,s ... promoter can be used to direct other introduced genes to ...
... University of Illinois metabolic engineer has taken the first ... biofuels by developing a strain of yeast with increased ... of biomass crops, which yield the alcohol-based fuels ethanol ... to convert sugars from biomass into biofuels. ...
Cached Biology News:Researchers discover how the storehouses of plant cells are formed 2Researchers discover how the storehouses of plant cells are formed 3New genetic tool helps improve rice 2Scientist IDs genes that promise to make biofuel production more efficient, economical 2